Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
24
pubmed:dateCreated
2010-12-16
pubmed:abstractText
Women who carry a deleterious mutation in BRCA1 or BRCA2 have high lifetime risks of breast and ovarian cancers. However, the influence of a family history of these cancers on these risks in women with BRCA mutations is unclear. We calculated cancer incidence rates for a multinational cohort comprising 3011 women with BRCA1 or BRCA2 mutations who were followed up for a mean of 3.9 years, during which time 243 incident breast or ovarian cancers were recorded. The 10-year cumulative risks of breast cancer were 18.1% (95% confidence interval [CI] = 13.3% to 22.8%) for women with a BRCA1 mutation and 15.2% (95% CI = 9.1% to 21.2%) for women with a BRCA2 mutation. Among women with a BRCA1 mutation, the risk of breast cancer increased by 1.2-fold for each first-degree relative with breast cancer before age 50 years (hazard ratio [HR] = 1.21; 95% confidence interval [CI] = 0.94 to 1.57) and the risk of ovarian cancer increased by 1.6 fold for each first- or second-degree relative with ovarian cancer (HR = 1.61; 95% CI = 1.21 to 2.14). Among women with a BRCA2 mutation, the risk of breast cancer increased by 1.7-fold for each first-degree relative younger than 50 years with breast cancer (HR = 1.67; 95% CI = 1.04 to 2.07).
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Dec
pubmed:issn
1460-2105
pubmed:author
pubmed:issnType
Electronic
pubmed:day
15
pubmed:volume
102
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1874-8
pubmed:meshHeading
pubmed-meshheading:21098759-Adult, pubmed-meshheading:21098759-Age Factors, pubmed-meshheading:21098759-Aged, pubmed-meshheading:21098759-BRCA1 Protein, pubmed-meshheading:21098759-BRCA2 Protein, pubmed-meshheading:21098759-Breast Neoplasms, pubmed-meshheading:21098759-Cohort Studies, pubmed-meshheading:21098759-Female, pubmed-meshheading:21098759-Genetic Predisposition to Disease, pubmed-meshheading:21098759-Heterozygote, pubmed-meshheading:21098759-Humans, pubmed-meshheading:21098759-Middle Aged, pubmed-meshheading:21098759-Mutation, pubmed-meshheading:21098759-Odds Ratio, pubmed-meshheading:21098759-Ovarian Neoplasms, pubmed-meshheading:21098759-Predictive Value of Tests, pubmed-meshheading:21098759-Prospective Studies, pubmed-meshheading:21098759-Risk Assessment, pubmed-meshheading:21098759-Risk Factors
pubmed:year
2010
pubmed:articleTitle
Family history of cancer and cancer risks in women with BRCA1 or BRCA2 mutations.
pubmed:affiliation
Women's College Research Institute, Toronto, ON, Canada.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't, Multicenter Study